Literature DB >> 28991363

MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.

Jung Woo Eun1,2, Hyung Seok Kim1,2, Qingyu Shen1,2, Hee Doo Yang1,2, Sang Yean Kim1,2, Jung Hwan Yoon1,2, Won Sang Park1,2, Jung Young Lee1,2, Suk Woo Nam1,2,3.   

Abstract

MicroRNAs (miRNAs) engage in complex interactions with the machinery that controls the transcriptome and concurrently target multiple mRNAs. Here, we demonstrate that microRNA-495-3p (miR-495-3p) functions as a potent tumor suppressor by governing ten oncogenic epigenetic modifiers (EMs) in gastric carcinogenesis. From the large cohort transcriptome datasets of gastric cancer (GC) patients available from The Cancer Genome Atlas (TCGA) and the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO), we were able to recapitulate 15 EMs as significantly overexpressed in GC among the 51 EMs that were previously reported to be involved in cancer progression. Computational target prediction yielded miR-495-3p, which targets as many as ten of the 15 candidate oncogenic EMs. Ectopic expression of miRNA mimics in GC cells caused miR-495-3p to suppress ten EMs, and inhibited tumor cell growth and proliferation via caspase-dependent and caspase-independent cell death processing. In addition, in vitro metastasis assays showed that miR-495-3p plays a role in the metastatic behavior of GC cells by regulating SLUG, vimentin, and N-cadherin. Furthermore, treatment of GC cells with 5-aza-2'-deoxcytidine restored miR-495-3p expression; sequence analysis revealed hypermethylation of the miR-495-3p promoter region in GC cells. A negative regulatory loop is proposed, whereby DNMT1, among ten oncogenic EMs, regulates miR-495-3p expression via hypermethylation of the miR-495-3p promoter. Our findings suggest that the functional loss or suppression of miR-495-3p triggers overexpression of multiple oncogenic EMs, and thereby contributes to malignant transformation and growth of gastric epithelial cells.
Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  epigenetic modifiers; gastric cancer; microRNA-495-3p; tumor suppressor

Mesh:

Substances:

Year:  2017        PMID: 28991363     DOI: 10.1002/path.4994

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

1.  Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p.

Authors:  Fengling Chen; Ling Liu; Shuya Wang
Journal:  Cancer Cell Int       Date:  2020-07-18       Impact factor: 5.722

2.  MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer.

Authors:  J Tang; H Pan; W Wang; C Qi; C Gu; A Shang; J Zhu
Journal:  Clin Transl Oncol       Date:  2021-08-13       Impact factor: 3.405

3.  FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma.

Authors:  Gaoming Wang; Xiaokun Li; Yu Yao; Zhisheng Jiang; Hai Zhou; Kai Xie; Jing Luo; Yi Shen
Journal:  Oncol Lett       Date:  2021-02-17       Impact factor: 2.967

Review 4.  MicroRNAs are involved in the development and progression of gastric cancer.

Authors:  Xiaolin Liu; Ruixia Ma; Bin Yi; Adam I Riker; Yaguang Xi
Journal:  Acta Pharmacol Sin       Date:  2020-10-09       Impact factor: 7.169

5.  Knockdown circZNF131 Inhibits Cell Progression and Glycolysis in Gastric Cancer Through miR-186-5p/PFKFB2 Axis.

Authors:  Xingjie Shen; Xiaoyan Zhu; Peixin Hu; Tingting Ji; Ying Qin; Jingyu Zhu
Journal:  Biochem Genet       Date:  2022-01-21       Impact factor: 2.220

6.  Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.

Authors:  Bin Song; Juan Du; De-Feng Song; Ji-Chen Ren; Ye Feng
Journal:  Biol Res       Date:  2018-11-03       Impact factor: 5.612

7.  Multiple genetic mutations caused by NKX6.3 depletion contribute to gastric tumorigenesis.

Authors:  Jung Hwan Yoon; Olga Kim; Jung Woo Eun; Sung Sook Choi; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Won Sang Park
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

8.  Pseudogene legumain promotes thyroid carcinoma progression via the microRNA-495/autophagy pathway.

Authors:  Jie Sun; Yicheng Peng; Jianxia Liu; Hao Zhou; Liang Sun; Qin He; Enqiao Yu
Journal:  Oncol Lett       Date:  2021-06-24       Impact factor: 2.967

9.  The prognostic and diagnostic values of MicroRNA-10b in gastric cancer: A comprehensive study based on meta-analysis and TCGA database.

Authors:  Lina Mei; Zhouxiang Lu; Zhangguo Shen; Sumei Xu
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

10.  MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer.

Authors:  Sheng Chen; Jian Wu; Kai Jiao; Qiong Wu; Jiaojiao Ma; Di Chen; Jianqin Kang; Guodong Zhao; Yongquan Shi; Daiming Fan; Guohong Zhao
Journal:  Cell Death Dis       Date:  2018-10-19       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.